Sequence of administration and methylation of SOCS3 may govern response to gemtuzumab ozogamicin in combination with conventional chemotherapy in patients with refractory or relapsed acute myelogenous leukemia (AML)

✍ Scribed by Iris Middeldorf; Oliver Galm; Rainhardt Osieka; Edgar Jost; James G. Herman; Stefan Wilop

• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 194 KB
• Volume: 85
• Category: Article
• ISSN: 0361-8609
• DOI: 10.1002/ajh.21723